These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1343 related articles for article (PubMed ID: 2883575)

  • 1. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    CONSENSUS Trial Study Group
    N Engl J Med; 1987 Jun; 316(23):1429-35. PubMed ID: 2883575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).
    Swedberg K; Kjekshus J
    Am J Cardiol; 1988 Jul; 62(2):60A-66A. PubMed ID: 2839019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability of enalapril in congestive heart failure.
    Kjekshus J; Swedberg K
    Am J Cardiol; 1988 Jul; 62(2):67A-72A. PubMed ID: 2839020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enalapril for congestive heart failure.
    Kjekshus J; Swedberg K
    Am J Cardiol; 1989 Feb; 63(8):26D-32D. PubMed ID: 2537563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.
    ; Yusuf S; Pitt B; Davis CE; Hood WB; Cohn JN
    N Engl J Med; 1991 Aug; 325(5):293-302. PubMed ID: 2057034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II).
    Swedberg K; Held P; Kjekshus J; Rasmussen K; Rydén L; Wedel H
    N Engl J Med; 1992 Sep; 327(10):678-84. PubMed ID: 1495520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure.
    Cohn JN; Johnson G; Ziesche S; Cobb F; Francis G; Tristani F; Smith R; Dunkman WB; Loeb H; Wong M
    N Engl J Med; 1991 Aug; 325(5):303-10. PubMed ID: 2057035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions.
    ; Yusuf S; Pitt B; Davis CE; Hood WB; Cohn JN
    N Engl J Med; 1992 Sep; 327(10):685-91. PubMed ID: 1463530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril. An update of its pharmacological properties and therapeutic use in congestive heart failure.
    Todd PA; Goa KL
    Drugs; 1989 Feb; 37(2):141-61. PubMed ID: 2539290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ACE-inhibition on renal function in severe congestive heart failure.
    Swedberg K
    Z Kardiol; 1991; 80 Suppl 2():50-4. PubMed ID: 2024543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I.
    Swedberg K; Kjekshus J; Snapinn S
    Eur Heart J; 1999 Jan; 20(2):136-9. PubMed ID: 10099910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-dose hypotension after angiotensin-converting enzyme (ACE) inhibitors in chronic heart failure: a comparison of enalapril and perindopril. Slovak Investigator Group.
    Vítovec J; Spinar J
    Eur J Heart Fail; 2000 Sep; 2(3):299-304. PubMed ID: 10938492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
    Dickstein K; Chang P; Willenheimer R; Haunsø S; Remes J; Hall C; Kjekshus J
    J Am Coll Cardiol; 1995 Aug; 26(2):438-45. PubMed ID: 7608448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the safety and efficacy of delapril with enalapril in patients with congestive heart failure.
    Rengo F; Acanfora D; Furgi G; Papa A; Nicolino A; Picone C; Vitale DF; Rengo C
    Am J Cardiol; 1995 Jun; 75(18):25F-28F. PubMed ID: 7778530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons from recent randomized controlled trials for the management of congestive heart failure.
    Riegger GA
    Am J Cardiol; 1993 Jun; 71(17):38E-40E. PubMed ID: 8328366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study.
    MacFadyen RJ; Lees KR; Reid JL
    Br Heart J; 1991 Sep; 66(3):206-11. PubMed ID: 1657084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of prerandomization (baseline) variables on mortality and on the reduction of mortality by enalapril. Veterans Affairs Cooperative Study on Vasodilator Therapy of Heart Failure (V-HeFT II). V-HeFT VA Cooperative Studies Group.
    Johnson G; Carson P; Francis GS; Cohn JN
    Circulation; 1993 Jun; 87(6 Suppl):VI32-9. PubMed ID: 8500237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between aspirin and angiotensin-converting enzyme inhibitors: should they be used together in older adults with heart failure?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1293-6. PubMed ID: 12133028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of two different enalapril dosages on clinical, haemodynamic and neurohumoral response of patients with severe congestive heart failure.
    Pacher R; Stanek B; Globits S; Berger R; Hülsmann M; Wutte M; Frey B; Schuller M; Hartter E; Ogris E
    Eur Heart J; 1996 Aug; 17(8):1223-32. PubMed ID: 8869864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First dose hypotension with enalapril and prazosin in congestive heart failure.
    Hasford J; Bussmann WD; Delius W; Koepcke W; Lehmann K; Weber E
    Int J Cardiol; 1991 Jun; 31(3):287-93. PubMed ID: 1879978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 68.